Predictive Factors for Failure of Non-Invasive Ventilation in Hospitalized Patients with Cancer

Detalhes bibliográficos
Autor(a) principal: Araujo, Bianca Paraiso de
Data de Publicação: 2019
Outros Autores: Faria, Eduarda Martins de, Silva, Larissy Machado da, Bizzo, Luciana Velasco, Quintão, Mônica Maria Pena, Bergmann, Anke, Thuler, Luiz Claudio Santos, Silva, Gustavo Telles da
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/322
Resumo: Introduction: The non-invasive ventilation (NIV) presents confirmed benefits in various clinical conditions, however, the results in patients with cancer are controversial. Objective: To analyze the predicting factors for failure of the NIV in cancer patients; To describe hospital mortality and overall survival after admission. Method: Study of retrospective cohort including patients with solid tumors and hematological neoplasm who have been admitted to the hospital stay at Hospital of Cancer I of the National Cancer Institute (HCI/INCA) between Jan 1 st and Dec 31 2017 and were submitted to NIV. The association between the exposure (clinical and socio-demographic variables) and the outcome (NIV failure) was performed by gross and adjusted logistic regression. The Kaplan-Meier method was used to analyze the overall survival. Results: Sixty-six patients with mean age of 62.3 years (± 15.0 years) were included. The average lasting time of the first session was 49.8 min (±30.9), the average number of sessions was 2.1 (±1.4). The patients who showed failure had longer time hospital stay (11.8 days vs 6.0 days) and higher hospital mortality (90.9 vs 43.6%). The patients with lung infection showed a higher risk of 4.71 times of failure in NIV related to those patients who showed succeeding (OR 4.71; IC 95%, 1.14-19.47; p=0.032). Conclusion: Patients who showed lung infection were more likely to failure in NIV. Was observed a worst overall survival between those patients who failed in NIV.
id INCA-1_932521ba5c5162d2e1c05baf236fe79d
oai_identifier_str oai:rbc.inca.gov.br:article/322
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Predictive Factors for Failure of Non-Invasive Ventilation in Hospitalized Patients with CancerFactores Predictores para la Falla de la Ventilación no Invasiva en Pacientes Hospitalizados con CâncerFatores Preditores para a Falha da Ventilação não Invasiva em Pacientes Hospitalizados com CâncerAnálise de SobrevidaVentilação não InvasivaNeoplasiasSurvival AnalysisNoninvasive VentilationNeoplasmAnálisis de SupervivenciaVentilación no InvasivaNeoplasiasIntroduction: The non-invasive ventilation (NIV) presents confirmed benefits in various clinical conditions, however, the results in patients with cancer are controversial. Objective: To analyze the predicting factors for failure of the NIV in cancer patients; To describe hospital mortality and overall survival after admission. Method: Study of retrospective cohort including patients with solid tumors and hematological neoplasm who have been admitted to the hospital stay at Hospital of Cancer I of the National Cancer Institute (HCI/INCA) between Jan 1 st and Dec 31 2017 and were submitted to NIV. The association between the exposure (clinical and socio-demographic variables) and the outcome (NIV failure) was performed by gross and adjusted logistic regression. The Kaplan-Meier method was used to analyze the overall survival. Results: Sixty-six patients with mean age of 62.3 years (± 15.0 years) were included. The average lasting time of the first session was 49.8 min (±30.9), the average number of sessions was 2.1 (±1.4). The patients who showed failure had longer time hospital stay (11.8 days vs 6.0 days) and higher hospital mortality (90.9 vs 43.6%). The patients with lung infection showed a higher risk of 4.71 times of failure in NIV related to those patients who showed succeeding (OR 4.71; IC 95%, 1.14-19.47; p=0.032). Conclusion: Patients who showed lung infection were more likely to failure in NIV. Was observed a worst overall survival between those patients who failed in NIV.Introducción: La ventilación no invasiva (VNI) muestra beneficios comprobados en diversos cuadros clínicos, sin embargo, hay controversia en los resultados presentados en pacientes con cáncer. Objetivos: Analizar los factores predictores para falla de la VNI en pacientes oncológicos; Describir la mortalidad hospitalaria y sobrevida global después de la internación. Método: Estudio de corte retrospectivo incluyendo pacientes con tumores sólidos y neoplastias hematológicas, dmitidos para internación hospitalar en el Hospital de Cáncer I del Instituto Nacional de Cáncer (HCI/INCA) entre el 1ro de enero y 31 de diciembre de 2017 y que fueron sometidos a la VNI. La asociación entre las variables de exposición (variables clínicas y socio demográficas) y los resultados (falla en la VNI) fue realizada por regresión logística bruta y ajustada. Fue utilizado el método de Kaplan-Meier para el análisis de sobrevida global. Resultados: Fueron incluidos 66 pacientes con un promedio de edad de 62,3 años (±15,0). El tiempo promedio de VNI em primera sesión fue de 49,8 minutos (±30,9). El número promedio de sesiones fue de 2,1 (±1,4). Los pacientes que presentaron falla tuvieron mayor tiempo de internación hospitalaria (11,8 días vs 6,0 días) y mayor mortalidad hospitalaria (90,9 vs 43,6%). Los pacientes con infección pulmonar presentaron un riesgo 4,71 veces mayor de fallar en VNI en relación a aquellos pacientes que presentaron suceso (OR 4,71;  IC 9 5%, 1,14-19,47; p=0,032). Conclusión: Pacientes que presentaron infección pulmonar tuvieron mayor probabilidad en fallar en la VNI. Se observó peor sobrevida global entre aquellos pacientes que fallaron en la VNI.Introdução: A ventilação não invasiva (VNI) apresenta benefícios comprovados em diversas condições clínicas, entretanto, os resultados em pacientes com câncer são controversos. Objetivos: Analisar os fatores preditores para falha da VNI em pacientes oncológicos; descrever a mortalidade hospitalar e a sobrevida global após internação. Método: Estudo de coorte retrospectiva incluindo pacientes com tumores sólidos e neoplasias hematológicas, admitidos para internação hospitalar no Hospital do Câncer I do Instituto Nacional de Câncer José Alencar Gomes da Silva (HC I/INCA), entre 1º de janeiro e 31 de dezembro de 2017, e que foram submetidos à VNI. A associação entre as variáveis de exposição (variáveis clínicas e sociodemográficas) e os desfechos (falha na VNI) foi realizada pela regressão logística bruta e ajustada. Foi utilizado o método de Kaplan-Meier para análise da sobrevida global. Resultados: Foram incluídos 66 pacientes com média de idade de 62,3 anos (±15,0). O tempo médio de VNI na primeira sessão foi de 49,8 minutos (±30,9); o número médio de sessões foi de 2,1 (±1,4). Os pacientes que apresentaram falha tiveram maior tempo de internação hospitalar (11,8 dias vs 6,0 dias) e maior mortalidade hospitalar (90,9 vs 43,6%). Os pacientes com infecção pulmonar tiveram um risco de 4,71 vezes maior de falharem na VNI, em relação àqueles pacientes que apresentaram sucesso (OR 4,71; IC 95%, 1,14-19,47; p=0,032). Conclusão: Pacientes que apresentaram infecção pulmonar tiveram maior probabilidade em falhar na VNI. Foi observada pior sobrevida global entre aqueles pacientes que falharam na VNI.INCA2019-07-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/32210.32635/2176-9745.RBC.2019v65n1.322Revista Brasileira de Cancerologia; Vol. 65 No. 1 (2019): Jan./Feb./Mar.; e-10322Revista Brasileira de Cancerologia; Vol. 65 Núm. 1 (2019): enero/feb./marzo; e-10322Revista Brasileira de Cancerologia; v. 65 n. 1 (2019): jan./fev./mar.; e-103222176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporenghttps://rbc.inca.gov.br/index.php/revista/article/view/322/218https://rbc.inca.gov.br/index.php/revista/article/view/322/510Copyright (c) 2019 Revista Brasileira de Cancerologiainfo:eu-repo/semantics/openAccessAraujo, Bianca Paraiso deFaria, Eduarda Martins deSilva, Larissy Machado daBizzo, Luciana VelascoQuintão, Mônica Maria PenaBergmann, AnkeThuler, Luiz Claudio SantosSilva, Gustavo Telles da2021-11-29T20:04:17Zoai:rbc.inca.gov.br:article/322Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2021-11-29T20:04:17Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Predictive Factors for Failure of Non-Invasive Ventilation in Hospitalized Patients with Cancer
Factores Predictores para la Falla de la Ventilación no Invasiva en Pacientes Hospitalizados con Câncer
Fatores Preditores para a Falha da Ventilação não Invasiva em Pacientes Hospitalizados com Câncer
title Predictive Factors for Failure of Non-Invasive Ventilation in Hospitalized Patients with Cancer
spellingShingle Predictive Factors for Failure of Non-Invasive Ventilation in Hospitalized Patients with Cancer
Araujo, Bianca Paraiso de
Análise de Sobrevida
Ventilação não Invasiva
Neoplasias
Survival Analysis
Noninvasive Ventilation
Neoplasm
Análisis de Supervivencia
Ventilación no Invasiva
Neoplasias
title_short Predictive Factors for Failure of Non-Invasive Ventilation in Hospitalized Patients with Cancer
title_full Predictive Factors for Failure of Non-Invasive Ventilation in Hospitalized Patients with Cancer
title_fullStr Predictive Factors for Failure of Non-Invasive Ventilation in Hospitalized Patients with Cancer
title_full_unstemmed Predictive Factors for Failure of Non-Invasive Ventilation in Hospitalized Patients with Cancer
title_sort Predictive Factors for Failure of Non-Invasive Ventilation in Hospitalized Patients with Cancer
author Araujo, Bianca Paraiso de
author_facet Araujo, Bianca Paraiso de
Faria, Eduarda Martins de
Silva, Larissy Machado da
Bizzo, Luciana Velasco
Quintão, Mônica Maria Pena
Bergmann, Anke
Thuler, Luiz Claudio Santos
Silva, Gustavo Telles da
author_role author
author2 Faria, Eduarda Martins de
Silva, Larissy Machado da
Bizzo, Luciana Velasco
Quintão, Mônica Maria Pena
Bergmann, Anke
Thuler, Luiz Claudio Santos
Silva, Gustavo Telles da
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Araujo, Bianca Paraiso de
Faria, Eduarda Martins de
Silva, Larissy Machado da
Bizzo, Luciana Velasco
Quintão, Mônica Maria Pena
Bergmann, Anke
Thuler, Luiz Claudio Santos
Silva, Gustavo Telles da
dc.subject.por.fl_str_mv Análise de Sobrevida
Ventilação não Invasiva
Neoplasias
Survival Analysis
Noninvasive Ventilation
Neoplasm
Análisis de Supervivencia
Ventilación no Invasiva
Neoplasias
topic Análise de Sobrevida
Ventilação não Invasiva
Neoplasias
Survival Analysis
Noninvasive Ventilation
Neoplasm
Análisis de Supervivencia
Ventilación no Invasiva
Neoplasias
description Introduction: The non-invasive ventilation (NIV) presents confirmed benefits in various clinical conditions, however, the results in patients with cancer are controversial. Objective: To analyze the predicting factors for failure of the NIV in cancer patients; To describe hospital mortality and overall survival after admission. Method: Study of retrospective cohort including patients with solid tumors and hematological neoplasm who have been admitted to the hospital stay at Hospital of Cancer I of the National Cancer Institute (HCI/INCA) between Jan 1 st and Dec 31 2017 and were submitted to NIV. The association between the exposure (clinical and socio-demographic variables) and the outcome (NIV failure) was performed by gross and adjusted logistic regression. The Kaplan-Meier method was used to analyze the overall survival. Results: Sixty-six patients with mean age of 62.3 years (± 15.0 years) were included. The average lasting time of the first session was 49.8 min (±30.9), the average number of sessions was 2.1 (±1.4). The patients who showed failure had longer time hospital stay (11.8 days vs 6.0 days) and higher hospital mortality (90.9 vs 43.6%). The patients with lung infection showed a higher risk of 4.71 times of failure in NIV related to those patients who showed succeeding (OR 4.71; IC 95%, 1.14-19.47; p=0.032). Conclusion: Patients who showed lung infection were more likely to failure in NIV. Was observed a worst overall survival between those patients who failed in NIV.
publishDate 2019
dc.date.none.fl_str_mv 2019-07-03
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigos, Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/322
10.32635/2176-9745.RBC.2019v65n1.322
url https://rbc.inca.gov.br/index.php/revista/article/view/322
identifier_str_mv 10.32635/2176-9745.RBC.2019v65n1.322
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/322/218
https://rbc.inca.gov.br/index.php/revista/article/view/322/510
dc.rights.driver.fl_str_mv Copyright (c) 2019 Revista Brasileira de Cancerologia
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Revista Brasileira de Cancerologia
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 65 No. 1 (2019): Jan./Feb./Mar.; e-10322
Revista Brasileira de Cancerologia; Vol. 65 Núm. 1 (2019): enero/feb./marzo; e-10322
Revista Brasileira de Cancerologia; v. 65 n. 1 (2019): jan./fev./mar.; e-10322
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042243526197248